ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3105-6741(Print)
ISSN 3105-675X(Online)

CODEN:LYYAA3
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/lyyaa3

WorldCat(世界图书馆目录)

OCLC 编号:11198178435

国图集团 CIBTC
进口备案刊号:G015Z125

索引 / 检索 / 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
ADL(亚洲数字图书馆,巴基斯坦)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)

Enterscholar(恩特学术,中国)

Scholay(Scholay学术,中国)

Minicod(学术数据 API,法国)

DiscountMags(折扣杂志,美国伊利诺伊)

Rootindexing(根索引,印度)

Synapse(突触,美国)

POSI(全景开放学术索引,中国香港)

GUL(乔治城大学图书馆,美国)

规划申请
Scopus 爱思唯尔·斯高帕斯(荷兰)

SinoMed 中国生物医学文献服务系统

DOAJ 开放获取期刊目录(瑞典)

PubMed 医学文摘数据库(美国)

PubMed Central 医学全文数据(美国)

EMBASE 爱思唯尔·医学文摘(荷兰)

EBSCO 学术文献数据库(美国)

OAJ 全球OA期刊索引(中国)

CABI 国际农业与生物科学中心(英国)

ProQuest 科睿唯安(美国)

Research4Life 世界卫生组织数据库

武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://lcyyyj.scionline2025.com

  往期阅览 · All Issues-> 2026年 · 2026  
临床用药研究,2026年,第2卷,第3期,第1-4页,pISSN 3105-6741、eISSN 3105-675X 发布者:Quest Press 发布日期:2026/11/2
Open Access 浏览163次

 

临床检验结果与临床诊断不符的危险因素及防控策略研究


杨璐

河南中医药大学第五临床医学院(郑州人民医院),河南郑州,450003

摘要:目的:系统分析临床检验结果与临床诊断不相符的核心危险因素,梳理检验全流程、临床诊疗及患者个体层面的各类风险点,制定针对性防控策略,旨在提升临床检验精准度、减少诊疗偏差、保障临床诊疗质量。方法:选取2024年10月—2025年10月我院收治的60例检验结果与临床诊断不符患者设为实验组,同期选取60例检验结果与临床诊断完全相符患者设为对照组。对比两组标本不合格率、检验操作不规范发生率,回溯性统计实验组诊断不符诱因分布特征,采用SPSS22.0统计学软件开展数据对比分析。结果:实验组标本不合格率38.33%、检验操作不规范率26.67%,均显著高于对照组的5.00%、3.33%,组间差异有统计学意义(P<0.05)。60例诊断不符病例诱因分布中,标本因素占比最高,为41.67%(25/60),其次为临床诊疗与患者自身因素30.00%(18/60)、检验操作与设备因素28.33%(17/60);标本溶血、病史采集不全、仪器未校准时为各类诱因中最主要风险项。结论:临床检验结果与临床诊断不符受标本、检验操作设备、临床诊疗及患者个体多维度因素共同影响,其中标本相关问题是首要危险因素,标本溶血、病史采集不全、仪器未校准为导致检验与诊断不符的核心关键风险点。标本不合格、检验操作不规范是造成检验诊断偏差的重要诱因,显著影响检验结果准确性。临床需针对检验全流程质控、临床诊疗信息采集、设备运维校准及患者管理等关键薄弱环节,建立针对性防控措施,强化各环节质量管控,可有效降低检验诊断不符事件发生率,提升临床检验精准度与整体诊疗质量。

关健词:临床检验;诊断不符;危险因素;全流程质控;检验误差;防控策略
Study on Risk Factors and Prevention?control Strategies for Inconsistency Between Clinical Laboratory Results and Clinical Diagnosis

Lu Yang

The Fifth Clinical Medical College of Henan University of Chinese Medicine(Zhengzhou People’s Hospital),Zhengzhou ,450003,China

Abstract:Objective:To systematically analyze the core risk factors for inconsistency between clinical laboratory results and clinical diagnosis,sort out risk points throughout the whole testing process,clinical diagnosis treatment and individual patient levels,and formulate targeted prevention control strategies,so as to improve the accuracy of clinical laboratory tests,reduce diagnosis treatment deviations and guarantee the quality of clinical diagnosis and treatment.Methods: A total of 60 patients with inconsistent laboratory results and clinical diagnosis admitted to our hospital from October 2024 to October 2025 were selected as the experimental group,and another 60 patients with completely consistent laboratory results and clinical diagnosis during the same period were selected as the control group. The unqualified specimen rate and the incidence of non standard testing operations were compared between the two groups. The distribution characteristics of inducing factors for diagnostic inconsistency in the experimental group were retrospectively analyzed. SPSS 22.0 statisticalsoftware was adopted for comparative data analysis.Results:The unqualified specimen rate and the rate of non standard testing operations in the experimental group were 38.33% and 26.67% respectively,which were significantly higher than 5.00% and 3.33% in the control group,with statistically significant differences between groups(*P*<0.05). Among the 60 cases with diagnostic inconsistency,specimen related factors accounted for the highest proportion of 41.67%(25/60),followed by clinical diagnosis treatment and patient related factors(30.00%,18/60),and testing operation and equipment related factors(28.33%,17/60). Specimen hemolysis,incomplete medical history collection and uncalibrated instruments were the predominant risk items among various inducing factors.Conclusion:The inconsistency between clinical laboratory results and clinical diagnosis is jointly affected by multi dimensional factors including specimens,testing operations and equipment,clinical diagnosis treatment and individual patients. Specimen related problems serve as the primary risk factor,and specimen hemolysis,incomplete medical history collection and uncalibrated instruments are the key risk points leading to the inconsistency. Unqualified specimens and non standard testing operations are important triggers for deviations between laboratory tests and clinical diagnosis,which markedly affect the accuracy of laboratory results. Targeted prevention control measures should be established for key weak links such as whole process quality control of laboratory testing,collection of clinical diagnosis treatment information,equipment maintenance calibration and patient management. Strengthening quality control in each link can effectively reduce the incidence of inconsistency events,and improve the accuracy of clinical laboratory tests and overall diagnosis treatment quality.


Keywords : clinical laboratory test;diagnostic inconsistency;risk factor;whole‑process quality control;laboratory error;prevention‑control strategy


参考文献
[1] 中华人民共和国国家卫生健康委员会. 医疗机构临床实验室管理办法[S]. 2024.
[2] 刘敏鸽,冯芳芳,董旭才,等.临床检验前误差的危险因素分析及质控对策研究[J]. 检验医学,2024,39(07):689-693.
[3] 黄静,宋江勤,朱心远.检验设备与试剂质控缺陷对临床检测结果的影响[J]. 中华临床实验室管理电子杂志,2025,13(02):89-94.
[4] 季晗,叶绍卿.临床检验结果与临床诊断不匹配的原因及干预策略[J]. 中国医药指南,2025,23(18):102-104.
[5] 崔宏华.全流程质控在规避临床检验诊断偏差中的应用价值[J]. 中国实用医药,2024,19(32):178-181.
[6] 刘凤,李霞,吕丽云. 标本预处理不规范所致检验误差的临床溯源分析[J]. 中国卫生产业,2025,22(12):115-118.
[7] 俞淼,王祎. 临床检验多因素误差对疾病诊断的影响及防控体系构建[J]. 检验医学与临床,2026,23(01):92-95.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/。
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Macau Sino-Foreign Medical Publishing Ltd.(MSFMP)
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The MSFMP publishes articles under the following open access license.
Quest Press
is a member of the following organizations.